HDAC6 and Parkinson disease: Despite a growing body of evidence demonstrating that HDAC6 inhibition could play an anti-inflammatory role in PD [47], our results suggest that the effect of HDAC6 in neuroinflammation might be limited in a MPTP-induced mouse PD model.